WT

SEC source: 0001197950-26-000017 · f4_a1eus000009ufmtmaq-live.xml · nonDerivative · entry 1

Lilien R Jarrett · CIK 0001197950 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,080,245

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 24, 2025. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. All sales by the reporting person are subject to the Issuer's equity ownership requirements.

F2 · balance_after: Includes restricted stock awards vesting as to (i) 114,570 shares on January 25, 2027, (ii) 59,724 shares on January 25, 2028 and (iii) 23,785 shares on January 25, 2029.

SEC source: 0001268528-26-000004 · f4_a1eus0000096rm1maa-live.xml · nonDerivative · entry 1

PANKOPF TONIA L · CIK 0001268528 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,471.0051

F1 · balance_after: Includes restricted stock award that vests as to 5,509 shares on June 17, 2027.

SEC source: 0001853959-26-000002 · f4_a1eus0000096ruhmay-live.xml · nonDerivative · entry 1

Naidoo Shamla · CIK 0001853959 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,194

F1 · balance_after: Includes restricted stock award that vests as to 5,509 shares on June 17, 2027.

SEC source: 0001587815-26-000002 · f4_a1eus0000096rmdmay-live.xml · nonDerivative · entry 1

Mielke Daniela · CIK 0001587815 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,833

F1 · shares: Restricted stock units ("RSUs") issued to the Reporting Person pursuant to the Non-Employee Directors' Deferred Compensation Program under the 2022 Equity Plan. In accordance with an election made by the Reporting Person to defer receipt of her annual restricted stock award, the common stock underlying the RSUs will vest on June 17, 2027, and is payable on a one-for-one basis (one share of common stock for each RSU) upon the earliest of (i) January 1, 2029, (ii) a "separation from service" (as defined in Section 409A of the Internal Revenue Code of 1986, as amended (Code)) and (iii) a Sale Event (as defined in the 2022 Equity Plan) so long as such Sale Event also constitutes a "change in the ownership or effective control" or a "change in the ownership of a substantial portion of the assets" of the Issuer (as such terms are defined in Code Section 409A).

SEC source: 0001548685-26-000008 · f4_a1eus0000096rizmai-live.xml · nonDerivative · entry 1

Delorier Rilla S · CIK 0001548685 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,360

F1 · balance_after: Includes restricted stock award that vests as to 5,509 shares on June 17, 2027.

SEC source: 0001656600-26-000004 · f4_a1eus0000096qzdmaa-live.xml · nonDerivative · entry 1

Conjeevaram Smita · CIK 0001656600 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,877

F1 · shares: Restricted stock units ("RSUs") issued to the Reporting Person pursuant to the Non-Employee Directors' Deferred Compensation Program under the 2022 Equity Plan. In accordance with an election made by the Reporting Person to defer receipt of her annual restricted stock award, the common stock underlying the RSUs will vest on June 17, 2027, and is payable on a one-for-one basis (one share of common stock for each RSU) upon the earliest of (i) June 30, 2027, (ii) a "separation from service" (as defined in Section 409A of the Internal Revenue Code of 1986, as amended (Code)) and (iii) a Sale Event (as defined in the 2022 Equity Plan) so long as such Sale Event also constitutes a "change in the ownership or effective control" or a "change in the ownership of a substantial portion of the assets" of the Issuer (as such terms are defined in Code Section 409A).

SEC source: 0001526062-26-000002 · f4_a1eus0000096qmjmaa-live.xml · nonDerivative · entry 1

Bossone Anthony · CIK 0001526062 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 650,898

F1 · shares: Restricted stock units ("RSUs") issued to the Reporting Person pursuant to the Non-Employee Directors' Deferred Compensation Program under the 2022 Equity Plan. In accordance with an election made by the Reporting Person to defer receipt of his annual restricted stock award, the common stock underlying the RSUs will vest on June 17, 2027, and is payable on a one-for-one basis (one share of common stock for each RSU) upon the earlier of (i) a "separation from service" (as defined in Section 409A of the Internal Revenue Code of 1986, as amended (Code)) and (ii) a Sale Event (as defined in the 2022 Equity Plan) so long as such Sale Event also constitutes a "change in the ownership or effective control" or a "change in the ownership of a substantial portion of the assets" of the Issuer (as such terms are defined in Code Section 409A).

SEC source: 0001932079-26-000002 · f4_a1eus0000096qbdmai-live.xml · nonDerivative · entry 1

Blake Lynn S. · CIK 0001932079 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,571

F1 · shares: Restricted stock units ("RSUs") issued to the Reporting Person pursuant to the Non-Employee Directors' Deferred Compensation Program under the 2022 Equity Plan. In accordance with an election made by the Reporting Person to defer receipt of her annual restricted stock award, the common stock underlying the RSUs will vest on June 17, 2027, and is payable on a one-for-one basis (one share of common stock for each RSU) upon the earlier of (i) a "separation from service" (as defined in Section 409A of the Internal Revenue Code of 1986, as amended (Code)) and (ii) a Sale Event (as defined in the 2022 Equity Plan) so long as such Sale Event also constitutes a "change in the ownership or effective control" or a "change in the ownership of a substantial portion of the assets" of the Issuer (as such terms are defined in Code Section 409A).

SEC source: 0001237844-26-000008 · f4_a1eus0000098yhlmaa-live.xml · nonDerivative · entry 1

SALERNO FRANK · CIK 0001237844 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 228,345

F1 · balance_after: Includes restricted stock award that vests as to 5,509 shares on June 17, 2027.

SEC source: 0001197950-26-000015 · f4_a1eus000008qptmmae-live.xml · nonDerivative · entry 1

Lilien R Jarrett · CIK 0001197950 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,110,245

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 24, 2025. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. All sales by the reporting person are subject to the Issuer's equity ownership requirements.

F2 · balance_after: Includes restricted stock awards vesting as to (i) 114,570 shares on January 25, 2027, (ii) 59,724 shares on January 25, 2028 and (iii) 23,785 shares on January 25, 2029.

SEC source: 0001064674-26-000010 · f4_a1eus000008pnwjmai-live.xml · nonDerivative · entry 1

Ziemba Peter M · CIK 0001064674 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 885,686

F2 · price: The price included in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $19.25 to $19.34, inclusive. The reporting person undertakes to provide to WisdomTree, Inc., any security holder of WisdomTree, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4.

F1 · balance_after: Includes restricted stock awards vesting as to (i) 44,646 shares on January 25, 2027, (ii) 22,733 shares on January 25, 2028 and (iii) 8,619 shares on January 25, 2029.

SEC source: 0001916322-26-000011 · f4_a1eus000008hlzfma2-live.xml · nonDerivative · entry 1

Yates David M · CIK 0001916322 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,499

F1 · balance_after: Includes restricted stock awards vesting as to (i) 35,859 shares on January 25, 2027, (ii) 19,116 shares on January 25, 2028 and (iii) 7,564 shares on January 25, 2029.

SEC source: 0001197950-26-000013 · f4_a1eus0000086rslma2-live.xml · nonDerivative · entry 1

Lilien R Jarrett · CIK 0001197950 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,140,245

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 24, 2025. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. All sales by the reporting person are subject to the Issuer's equity ownership requirements.

F2 · balance_after: Includes restricted stock awards vesting as to (i) 114,570 shares on January 25, 2027, (ii) 59,724 shares on January 25, 2028 and (iii) 23,785 shares on January 25, 2029.

SEC source: 0001268528-26-000002 · f4_a1eus000008alwdmaw-live.xml · nonDerivative · entry 6

PANKOPF TONIA L · CIK 0001268528 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,962.0051

F1 · shares: Represents shares acquired via dividend reinvestment pursuant to a dividend reinvestment plan sponsored by a broker-dealer.

F2 · balance_after: Includes restricted stock awards which vests as to 9,871 shares on June 17, 2026.

SEC source: 0001784344-26-000009 · f4_a1eus0000085khrmau-live.xml · derivative · entry 1

Marinof Alexis · CIK 0001784344 · CEO, Europe

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,223

Underlying: Common Stock · 5,223 shares

Expires not disclosed

F1 · security: On January 25, 2026, the Compensation Committee of the Issuer's Board of Directors approved a grant of performance-based restricted stock units ("PRSUs") initially reported on a Form 4 filed January 27, 2026 and amended February 24, 2026 ("Prior Form 4"), with the target number of PRSUs determined based on the grant-date fair value calculated using a Monte Carlo valuation methodology. On February 23, 2026, the Compensation Committee approved a change in the methodology for determining PRSU target shares to one based on the Issuer's grant date closing stock price and, in connection with that change, approved a separate, additional grant of PRSUs to the Reporting Person equal to the difference between (i) the target number of PRSUs reported in the Prior Form 4 and (ii) the target number of PRSUs determined using the Issuer's closing stock price on January 25, 2026. This grant is intended to qualify for the Rule 16b-3 exemption under the Securities Exchange Act of 1934.

F2 · derivative.exercise_price: Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each unit that vests.

F3 · derivative.exercise_date: These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

F3 · derivative.expiration_date: These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

SEC source: 0001916322-26-000008 · f4_a1eus0000085khdmam-live.xml · derivative · entry 1

Yates David M · CIK 0001916322 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,673

Underlying: Common Stock · 2,673 shares

Expires not disclosed

F1 · security: On January 25, 2026, the Compensation Committee of the Issuer's Board of Directors approved a grant of performance-based restricted stock units ("PRSUs") initially reported on a Form 4 filed January 27, 2026 and amended February 24, 2026 ("Prior Form 4"), with the target number of PRSUs determined based on the grant-date fair value calculated using a Monte Carlo valuation methodology. On February 23, 2026, the Compensation Committee approved a change in the methodology for determining PRSU target shares to one based on the Issuer's grant date closing stock price and, in connection with that change, approved a separate, additional grant of PRSUs to the Reporting Person equal to the difference between (i) the target number of PRSUs reported in the Prior Form 4 and (ii) the target number of PRSUs determined using the Issuer's closing stock price on January 25, 2026. This grant is intended to qualify for the Rule 16b-3 exemption under the Securities Exchange Act of 1934.

F2 · derivative.exercise_price: Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each unit that vests.

F3 · derivative.exercise_date: These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

F3 · derivative.expiration_date: These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

SEC source: 0001527031-26-000008 · f4_a1eus0000085kg1mam-live.xml · derivative · entry 1

Edmiston Bryan · CIK 0001527031 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,247

Underlying: Common Stock · 4,247 shares

Expires not disclosed

F1 · security: On January 25, 2026, the Compensation Committee of the Issuer's Board of Directors approved a grant of performance-based restricted stock units ("PRSUs") initially reported on a Form 4 filed January 27, 2026 and amended February 24, 2026 ("Prior Form 4"), with the target number of PRSUs determined based on the grant-date fair value calculated using a Monte Carlo valuation methodology. On February 23, 2026, the Compensation Committee approved a change in the methodology for determining PRSU target shares to one based on the Issuer's grant date closing stock price and, in connection with that change, approved a separate, additional grant of PRSUs to the Reporting Person equal to the difference between (i) the target number of PRSUs reported in the Prior Form 4 and (ii) the target number of PRSUs determined using the Issuer's closing stock price on January 25, 2026. This grant is intended to qualify for the Rule 16b-3 exemption under the Securities Exchange Act of 1934.

F2 · derivative.exercise_price: Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each unit that vests.

F3 · derivative.exercise_date: These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

F3 · derivative.expiration_date: These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

SEC source: 0001815934-26-000008 · f4_a1eus0000085jdjmau-live.xml · derivative · entry 1

Peck William Bradley · CIK 0001815934 · Head of Digital Assets

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,673

Underlying: Common Stock · 2,673 shares

Expires not disclosed

F1 · security: On January 25, 2026, the Compensation Committee of the Issuer's Board of Directors approved a grant of performance-based restricted stock units ("PRSUs") initially reported on a Form 4 filed January 27, 2026 and amended February 24, 2026 ("Prior Form 4"), with the target number of PRSUs determined based on the grant-date fair value calculated using a Monte Carlo valuation methodology. On February 23, 2026, the Compensation Committee approved a change in the methodology for determining PRSU target shares to one based on the Issuer's grant date closing stock price and, in connection with that change, approved a separate, additional grant of PRSUs to the Reporting Person equal to the difference between (i) the target number of PRSUs reported in the Prior Form 4 and (ii) the target number of PRSUs determined using the Issuer's closing stock price on January 25, 2026. This grant is intended to qualify for the Rule 16b-3 exemption under the Securities Exchange Act of 1934.

F2 · derivative.exercise_price: Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each unit that vests.

F3 · derivative.exercise_date: These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

F3 · derivative.expiration_date: These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

SEC source: 0001064674-26-000008 · f4_a1eus0000085ipvma2-live.xml · derivative · entry 1

Ziemba Peter M · CIK 0001064674 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,046

Underlying: Common Stock · 3,046 shares

Expires not disclosed

F1 · security: On January 25, 2026, the Compensation Committee of the Issuer's Board of Directors approved a grant of performance-based restricted stock units ("PRSUs") initially reported on a Form 4 filed January 27, 2026 and amended February 24, 2026 ("Prior Form 4"), with the target number of PRSUs determined based on the grant-date fair value calculated using a Monte Carlo valuation methodology. On February 23, 2026, the Compensation Committee approved a change in the methodology for determining PRSU target shares to one based on the Issuer's grant date closing stock price and, in connection with that change, approved a separate, additional grant of PRSUs to the Reporting Person equal to the difference between (i) the target number of PRSUs reported in the Prior Form 4 and (ii) the target number of PRSUs determined using the Issuer's closing stock price on January 25, 2026. This grant is intended to qualify for the Rule 16b-3 exemption under the Securities Exchange Act of 1934.

F2 · derivative.exercise_price: Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each unit that vests.

F3 · derivative.exercise_date: These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

F3 · derivative.expiration_date: These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

SEC source: 0001197950-26-000008 · f4_a1eus0000085hwtmau-live.xml · derivative · entry 1

Lilien R Jarrett · CIK 0001197950 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,220

Underlying: Common Stock · 25,220 shares

Expires not disclosed

F1 · security: On January 25, 2026, the Compensation Committee of the Issuer's Board of Directors approved a grant of performance-based restricted stock units ("PRSUs") initially reported on a Form 4 filed January 27, 2026 and amended February 24, 2026 ("Prior Form 4"), with the target number of PRSUs determined based on the grant-date fair value calculated using a Monte Carlo valuation methodology. On February 23, 2026, the Compensation Committee approved a change in the methodology for determining PRSU target shares to one based on the Issuer's grant date closing stock price and, in connection with that change, approved a separate, additional grant of PRSUs to the Reporting Person equal to the difference between (i) the target number of PRSUs reported in the Prior Form 4 and (ii) the target number of PRSUs determined using the Issuer's closing stock price on January 25, 2026. This grant is intended to qualify for the Rule 16b-3 exemption under the Securities Exchange Act of 1934.

F2 · derivative.exercise_price: Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each unit that vests.

F3 · derivative.exercise_date: These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

F3 · derivative.expiration_date: These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

SEC source: 0000934992-26-000009 · f4_a1eus0000085hztmam-live.xml · derivative · entry 1

Steinberg Jonathan L · CIK 0000934992 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,880

Underlying: Common Stock · 42,880 shares

Expires not disclosed

F1 · security: On January 25, 2026, the Compensation Committee of the Issuer's Board of Directors approved a grant of performance-based restricted stock units ("PRSUs") initially reported on a Form 4 filed January 27, 2026 and amended February 24, 2026 ("Prior Form 4"), with the target number of PRSUs determined based on the grant-date fair value calculated using a Monte Carlo valuation methodology. On February 23, 2026, the Compensation Committee approved a change in the methodology for determining PRSU target shares to one based on the Issuer's grant date closing stock price and, in connection with that change, approved a separate, additional grant of PRSUs to the Reporting Person equal to the difference between (i) the target number of PRSUs reported in the Prior Form 4 and (ii) the target number of PRSUs determined using the Issuer's closing stock price on January 25, 2026. This grant is intended to qualify for the Rule 16b-3 exemption under the Securities Exchange Act of 1934.

F2 · derivative.exercise_price: Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each unit that vests.

F3 · derivative.exercise_date: These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

F3 · derivative.expiration_date: These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

SEC source: 0001772446-26-000009 · f4_a1eus00000852sbmaa-live.xml · derivative · entry 1

Frankenthaler Marci · CIK 0001772446 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,725

Underlying: Common Stock · 3,725 shares

Expires not disclosed

F1 · security: On January 25, 2026, the Compensation Committee of the Issuer's Board of Directors approved a grant of performance-based restricted stock units ("PRSUs") initially reported on a Form 4 filed January 27, 2026 and amended February 24, 2026 ("Prior Form 4"), with the target number of PRSUs determined based on the grant-date fair value calculated using a Monte Carlo valuation methodology. On February 23, 2026, the Compensation Committee approved a change in the methodology for determining PRSU target shares to one based on the Issuer's grant date closing stock price and, in connection with that change, approved a separate, additional grant of PRSUs to the Reporting Person equal to the difference between (i) the target number of PRSUs reported in the Prior Form 4 and (ii) the target number of PRSUs determined using the Issuer's closing stock price on January 25, 2026. This grant is intended to qualify for the Rule 16b-3 exemption under the Securities Exchange Act of 1934.

F2 · derivative.exercise_price: Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each unit that vests.

F3 · derivative.exercise_date: These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

F3 · derivative.expiration_date: These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

SEC source: 0001916322-26-000004 · f4_a1eus000007t4n7mai-live.xml · derivative · entry 3

Yates David M · CIK 0001916322 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,997 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F1 · shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · shares: Includes the reinvestment of dividend equivalents into 1,586 PRSUs between the grant date and vesting date.

F5 · shares: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F5 · derivative.exercise_date: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F5 · derivative.expiration_date: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F1 · derivative.underlying_shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · derivative.underlying_shares: Includes the reinvestment of dividend equivalents into 1,586 PRSUs between the grant date and vesting date.

F5 · derivative.underlying_shares: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

SEC source: 0001916322-26-000004 · f4_a1eus000007t4n7mai-live.xml · nonDerivative · entry 2

Yates David M · CIK 0001916322 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,499

F4 · shares: Shares withheld by the Issuer upon vesting of PRSUs to cover withholding taxes.

F3 · balance_after: Includes restricted stock awards vesting as to (i) 35,859 shares on January 25, 2027, (ii) 19,116 shares on January 25, 2028 and (iii) 7,564 shares on January 25, 2029.

SEC source: 0001916322-26-000004 · f4_a1eus000007t4n7mai-live.xml · nonDerivative · entry 1

Yates David M · CIK 0001916322 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,315

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · shares: Includes the reinvestment of dividend equivalents into 1,586 PRSUs between the grant date and vesting date.

F3 · balance_after: Includes restricted stock awards vesting as to (i) 35,859 shares on January 25, 2027, (ii) 19,116 shares on January 25, 2028 and (iii) 7,564 shares on January 25, 2029.

SEC source: 0001784344-26-000005 · f4_a1eus000007t3fzmaq-live.xml · derivative · entry 3

Marinof Alexis · CIK 0001784344 · CEO, Europe

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 45,713 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F1 · shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · shares: Includes the reinvestment of dividend equivalents into 1,908 PRSUs between the grant date and vesting date.

F5 · shares: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F5 · derivative.exercise_date: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F5 · derivative.expiration_date: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F1 · derivative.underlying_shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · derivative.underlying_shares: Includes the reinvestment of dividend equivalents into 1,908 PRSUs between the grant date and vesting date.

F5 · derivative.underlying_shares: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

SEC source: 0001784344-26-000005 · f4_a1eus000007t3fzmaq-live.xml · nonDerivative · entry 2

Marinof Alexis · CIK 0001784344 · CEO, Europe

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 256,272

F4 · shares: Shares withheld by the Issuer upon vesting of PRSUs to cover withholding taxes.

F3 · balance_after: Includes restricted stock awards vesting as to (i) 60,394 shares on January 25, 2027, (ii) 33,526 shares on January 25, 2028 and (iii) 14,777 shares on January 25, 2029.

SEC source: 0001784344-26-000005 · f4_a1eus000007t3fzmaq-live.xml · nonDerivative · entry 1

Marinof Alexis · CIK 0001784344 · CEO, Europe

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 277,758

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · shares: Includes the reinvestment of dividend equivalents into 1,908 PRSUs between the grant date and vesting date.

F3 · balance_after: Includes restricted stock awards vesting as to (i) 60,394 shares on January 25, 2027, (ii) 33,526 shares on January 25, 2028 and (iii) 14,777 shares on January 25, 2029.

SEC source: 0001772446-26-000005 · f4_a1eus000007t3ajmaa-live.xml · derivative · entry 3

Frankenthaler Marci · CIK 0001772446 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 43,998 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F1 · shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · shares: Includes the reinvestment of dividend equivalents into 1,838 PRSUs between the grant date and vesting date.

F5 · shares: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F5 · derivative.exercise_date: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F5 · derivative.expiration_date: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F1 · derivative.underlying_shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · derivative.underlying_shares: Includes the reinvestment of dividend equivalents into 1,838 PRSUs between the grant date and vesting date.

F5 · derivative.underlying_shares: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

SEC source: 0001772446-26-000005 · f4_a1eus000007t3ajmaa-live.xml · nonDerivative · entry 2

Frankenthaler Marci · CIK 0001772446 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 315,272

F4 · shares: Shares withheld by the Issuer upon vesting of PRSUs to cover withholding taxes.

F3 · balance_after: Includes restricted stock awards vesting as to (i) 51,943 shares on January 25, 2027, (ii) 28,277 shares on January 25, 2028 and (iii) 10,538 shares on January 25, 2029.

SEC source: 0001772446-26-000005 · f4_a1eus000007t3ajmaa-live.xml · nonDerivative · entry 1

Frankenthaler Marci · CIK 0001772446 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 338,161

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · shares: Includes the reinvestment of dividend equivalents into 1,838 PRSUs between the grant date and vesting date.

F3 · balance_after: Includes restricted stock awards vesting as to (i) 51,943 shares on January 25, 2027, (ii) 28,277 shares on January 25, 2028 and (iii) 10,538 shares on January 25, 2029.

SEC source: 0001064674-26-000004 · f4_a1eus000007t3z7mai-live.xml · derivative · entry 3

Ziemba Peter M · CIK 0001064674 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 61,005 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F1 · shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · shares: Includes the reinvestment of dividend equivalents into 2,555 PRSUs between the grant date and vesting date.

F5 · shares: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F5 · derivative.exercise_date: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F5 · derivative.expiration_date: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F1 · derivative.underlying_shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · derivative.underlying_shares: Includes the reinvestment of dividend equivalents into 2,555 PRSUs between the grant date and vesting date.

F5 · derivative.underlying_shares: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

SEC source: 0001064674-26-000004 · f4_a1eus000007t3z7mai-live.xml · nonDerivative · entry 2

Ziemba Peter M · CIK 0001064674 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 985,686

F4 · shares: Shares withheld by the Issuer upon vesting of PRSUs to cover withholding taxes.

F3 · balance_after: Includes restricted stock awards vesting as to (i) 44,646 shares on January 25, 2027, (ii) 22,733 shares on January 25, 2028 and (iii) 8,619 shares on January 25, 2029.

SEC source: 0001064674-26-000004 · f4_a1eus000007t3z7mai-live.xml · nonDerivative · entry 1

Ziemba Peter M · CIK 0001064674 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,017,249

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · shares: Includes the reinvestment of dividend equivalents into 2,555 PRSUs between the grant date and vesting date.

F3 · balance_after: Includes restricted stock awards vesting as to (i) 44,646 shares on January 25, 2027, (ii) 22,733 shares on January 25, 2028 and (iii) 8,619 shares on January 25, 2029.

SEC source: 0001197950-26-000004 · f4_a1eus000007t3hnmay-live.xml · derivative · entry 3

Lilien R Jarrett · CIK 0001197950 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 350,395 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F1 · shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · shares: Includes the reinvestment of dividend equivalents into 14,710 PRSUs between the grant date and vesting date.

F5 · shares: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F5 · derivative.exercise_date: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F5 · derivative.expiration_date: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F1 · derivative.underlying_shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · derivative.underlying_shares: Includes the reinvestment of dividend equivalents into 14,710 PRSUs between the grant date and vesting date.

F5 · derivative.underlying_shares: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

SEC source: 0001197950-26-000004 · f4_a1eus000007t3hnmay-live.xml · nonDerivative · entry 2

Lilien R Jarrett · CIK 0001197950 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,170,245

F4 · shares: Shares withheld by the Issuer upon vesting of PRSUs to cover withholding taxes.

F3 · balance_after: Includes restricted stock awards vesting as to (i) 114,570 shares on January 25, 2027, (ii) 59,724 shares on January 25, 2028 and (iii) 23,785 shares on January 25, 2029.

SEC source: 0001197950-26-000004 · f4_a1eus000007t3hnmay-live.xml · nonDerivative · entry 1

Lilien R Jarrett · CIK 0001197950 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,349,452

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · shares: Includes the reinvestment of dividend equivalents into 14,710 PRSUs between the grant date and vesting date.

F3 · balance_after: Includes restricted stock awards vesting as to (i) 114,570 shares on January 25, 2027, (ii) 59,724 shares on January 25, 2028 and (iii) 23,785 shares on January 25, 2029.

SEC source: 0000934992-26-000005 · f4_a1eus000007t31fmaq-live.xml · derivative · entry 4

Steinberg Jonathan L · CIK 0000934992 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 573,813 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F1 · shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · shares: Includes the reinvestment of dividend equivalents into 24,096 PRSUs between the grant date and vesting date.

F5 · shares: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F5 · derivative.exercise_date: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F5 · derivative.expiration_date: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F1 · derivative.underlying_shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · derivative.underlying_shares: Includes the reinvestment of dividend equivalents into 24,096 PRSUs between the grant date and vesting date.

F5 · derivative.underlying_shares: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

SEC source: 0000934992-26-000005 · f4_a1eus000007t31fmaq-live.xml · nonDerivative · entry 2

Steinberg Jonathan L · CIK 0000934992 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,763,318

F4 · shares: Shares withheld by the Issuer upon vesting of PRSUs to cover withholding taxes.

F3 · balance_after: Includes restricted stock awards vesting as to (i) 189,055 shares on January 25, 2027, (ii) 99,253 shares on January 25, 2028 and (iii) 40,439 shares on January 25, 2029.

SEC source: 0000934992-26-000005 · f4_a1eus000007t31fmaq-live.xml · nonDerivative · entry 1

Steinberg Jonathan L · CIK 0000934992 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,056,470

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · shares: Includes the reinvestment of dividend equivalents into 24,096 PRSUs between the grant date and vesting date.

F3 · balance_after: Includes restricted stock awards vesting as to (i) 189,055 shares on January 25, 2027, (ii) 99,253 shares on January 25, 2028 and (iii) 40,439 shares on January 25, 2029.

SEC source: 0001527031-26-000004 · f4_a1eus000007t2zdmaa-live.xml · derivative · entry 3

Edmiston Bryan · CIK 0001527031 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 43,998 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F1 · shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · shares: Includes the reinvestment of dividend equivalents into 1,838 PRSUs between the grant date and vesting date.

F5 · shares: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F5 · derivative.exercise_date: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F5 · derivative.expiration_date: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F1 · derivative.underlying_shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · derivative.underlying_shares: Includes the reinvestment of dividend equivalents into 1,838 PRSUs between the grant date and vesting date.

F5 · derivative.underlying_shares: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

SEC source: 0001527031-26-000004 · f4_a1eus000007t2zdmaa-live.xml · nonDerivative · entry 2

Edmiston Bryan · CIK 0001527031 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 271,667

F4 · shares: Shares withheld by the Issuer upon vesting of PRSUs to cover withholding taxes.

F3 · balance_after: Includes restricted stock awards vesting as to (i) 55,049 shares on January 25, 2027, (ii) 30,942 shares on January 25, 2028 and (iii) 12,016 shares on January 25, 2029.

SEC source: 0001527031-26-000004 · f4_a1eus000007t2zdmaa-live.xml · nonDerivative · entry 1

Edmiston Bryan · CIK 0001527031 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 294,555

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · shares: Includes the reinvestment of dividend equivalents into 1,838 PRSUs between the grant date and vesting date.

F3 · balance_after: Includes restricted stock awards vesting as to (i) 55,049 shares on January 25, 2027, (ii) 30,942 shares on January 25, 2028 and (iii) 12,016 shares on January 25, 2029.

SEC source: 0001815934-26-000004 · f4_a1eus000007t2htmaa-live.xml · derivative · entry 3

Peck William Bradley · CIK 0001815934 · Head of Digital Assets

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 39,996 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F1 · shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · shares: Includes the reinvestment of dividend equivalents into 1,669 PRSUs between the grant date and vesting date.

F5 · shares: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F5 · derivative.exercise_date: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F5 · derivative.expiration_date: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

F1 · derivative.underlying_shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · derivative.underlying_shares: Includes the reinvestment of dividend equivalents into 1,669 PRSUs between the grant date and vesting date.

F5 · derivative.underlying_shares: These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

SEC source: 0001815934-26-000004 · f4_a1eus000007t2htmaa-live.xml · nonDerivative · entry 2

Peck William Bradley · CIK 0001815934 · Head of Digital Assets

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 243,168

F4 · shares: Shares withheld by the Issuer upon vesting of PRSUs to cover withholding taxes.

F3 · balance_after: Includes restricted stock awards vesting as to (i) 37,773 shares on January 25, 2027, (ii) 19,365 shares on January 25, 2028 and (iii) 7,564 shares on January 25, 2029.

SEC source: 0001815934-26-000004 · f4_a1eus000007t2htmaa-live.xml · nonDerivative · entry 1

Peck William Bradley · CIK 0001815934 · Head of Digital Assets

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 264,540

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

F2 · shares: Includes the reinvestment of dividend equivalents into 1,669 PRSUs between the grant date and vesting date.

F3 · balance_after: Includes restricted stock awards vesting as to (i) 37,773 shares on January 25, 2027, (ii) 19,365 shares on January 25, 2028 and (iii) 7,564 shares on January 25, 2029.

SEC source: 0001064674-26-000002 · f4_a1eus000007rxhxmam-live.xml · derivative · entry 3

Ziemba Peter M · CIK 0001064674 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,617

Underlying: Common Stock · 8,617 shares

Expires not disclosed

F4 · derivative.exercise_price: Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each such unit that vests.

F5 · derivative.exercise_date: These performance-based restricted stock units ("PRSUs") are scheduled to vest on January 25, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stocks of the peer group, each measured from the grant date to the accelerated vesting date.

F5 · derivative.expiration_date: These performance-based restricted stock units ("PRSUs") are scheduled to vest on January 25, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stocks of the peer group, each measured from the grant date to the accelerated vesting date.

SEC source: 0001064674-26-000002 · f4_a1eus000007rxhxmam-live.xml · nonDerivative · entry 2

Ziemba Peter M · CIK 0001064674 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 956,244

F3 · shares: Surrender of common stock to Issuer upon vesting of restricted stock awards to cover withholding taxes.

F2 · balance_after: Includes restricted stock awards vesting as to (i) 44,646 shares on January 25, 2027, (ii) 22,733 shares on January 25, 2028 and (iii) 8,619 shares on January 25, 2029.

SEC source: 0001064674-26-000002 · f4_a1eus000007rxhxmam-live.xml · nonDerivative · entry 1

Ziemba Peter M · CIK 0001064674 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 983,503

F1 · shares: Restricted stock awarded by Issuer on January 25, 2026 and vesting as to (i) 8,617 shares on each of January 25, 2027 and January 25, 2028 and (ii) 8,619 shares on January 25, 2029.

F2 · balance_after: Includes restricted stock awards vesting as to (i) 44,646 shares on January 25, 2027, (ii) 22,733 shares on January 25, 2028 and (iii) 8,619 shares on January 25, 2029.

SEC source: 0001916322-26-000002 · f4_a1eus000007rxjzma2-live.xml · derivative · entry 3

Yates David M · CIK 0001916322 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,562

Underlying: Common Stock · 7,562 shares

Expires not disclosed

F4 · derivative.exercise_price: Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each such unit that vests.

F5 · derivative.exercise_date: These performance-based restricted stock units ("PRSUs") are scheduled to vest on January 25, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stocks of the peer group, each measured from the grant date to the accelerated vesting date.

F5 · derivative.expiration_date: These performance-based restricted stock units ("PRSUs") are scheduled to vest on January 25, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stocks of the peer group, each measured from the grant date to the accelerated vesting date.